Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon

Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition): Analysis By Product Type (Balloon Catheters, Stents, Guidewires, Others), By Application, By End User, By Region: Market Insights and Forecast (2020-2030)

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Executive Summary

Azoth Analytics has released a research report titled "Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition)" which provides a complete analysis of the Global Percutaneous Transluminal Angioplasty (PTA) industry in terms of market segmentation by Product Type (Balloon Catheters, Stents, Guidewires Others), by Application (Coronary Artery Disease, Peripheral Artery Disease), by End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom, Germany, France, Spain, China, India, Japan, South Korea). The Global Percutaneous Transluminal Angioplasty (PTA) market showcased growth at a CAGR of 10.25% during 2020-2023. The market was valued at USD 2.92 Billion in 2023 which is expected to reach USD 6.95 Billion in 2030. The global percutaneous transluminal angioplasty (PTA) market is driven by the rising prevalence of cardiovascular diseases, technological advancements, an aging population, growing awareness, improved healthcare infrastructure, favorable reimbursement policies, increased adoption of minimally invasive procedures, rising healthcare expenditure, medical tourism, and strategic industry collaboration.

According to World Heart Federation, more than half a billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021- close to a third of all deaths globally and an overall increase on the estimated 121 million CVD deaths. Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and cardiac arrhythmias, continue to be leading causes of morbidity and mortality globally. This surge in cardiovascular conditions creates a greater demand for effective, minimally invasive treatment options like PTA, which restore blood flow in blocked or narrowed arteries without the need for major surgery.

The growing awareness of minimally invasive options has led to increased patient demand for procedures like PTA. Patients often prefer minimally invasive techniques due to their perceived advantages, including reduced pain, scarring, and recovery time. Also, Healthcare providers are increasingly adopting minimally invasive techniques like PTA as standard practice in the management of CVDs. Advances in medical technology and techniques have made PTA procedures safer, more effective, and easier to perform, leading to greater acceptance among clinicians.

Drug-coated balloon (DCB) technology represents a significant advancement in balloon catheters for percutaneous transluminal angioplasty (PTA). These balloons are coated with anti-proliferative drugs, such as paclitaxel or sirolimus, which are released locally into the arterial wall during inflation. This targeted drug delivery helps to inhibit smooth muscle cell proliferation and reduce neointimal hyperplasia, thereby improving long-term vessel patency compared to traditional uncoated balloons. DCBs have demonstrated efficacy in reducing restenosis rates and the need for repeat interventions, particularly in complex lesions or small vessels. This technology offers a promising approach to improving the outcomes of PTA procedures by addressing one of the primary challenges associated with angioplasty—restenosis.

Advanced imaging modalities, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), play a crucial role in enhancing the treatment of peripheral artery disease (PAD). IVUS and OCT provide high-resolution imaging of peripheral arteries, allowing for precise lesion assessment and treatment planning. By offering real-time guidance during PTA procedures, IVUS and OCT help optimize balloon sizing, stent placement, and post-dilation techniques, leading to improved procedural outcomes and reduced rates of complications in PAD patients. This feature represents a significant advancement in the treatment of PAD, providing clinicians with invaluable tools to enhance procedural precision and patient care in the global PTA market.

Advancements in precision medicine and personalized therapies aim to tailor PTA treatments to individual patient characteristics, including genetic predispositions, disease phenotypes, and response profiles. Biomarker-guided interventions, patient-specific treatment algorithms, and targeted drug delivery systems offer opportunities to optimize treatment outcomes and minimize adverse events in PTA procedures.

Scope of the Report:

• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Value (USD Million).
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Epidemiology.
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, United Kingdom, Germany, France, Spain, China, India, Japan, South Korea).
• The report presents the analysis of Percutaneous Transluminal Angioplasty (PTA) Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Product Type (Balloon Catheters, Stents, Guidewires, Others).
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by Application (Coronary Artery Disease, Peripheral Artery Disease).
• The report analyses the Percutaneous Transluminal Angioplasty (PTA) Market by End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by product type, by application, & by end user.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Medtronic PLC, Terumo Corporation, Cardinal Health, Boston Scientific, Teleflex Incorporated, Johnson & Johnson, Abbott Laboratories, Stryker Corporation, Becton Dickinson and Co, and Cook Group Inc.

Table of Content

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Strategic Recommendations
2.1 Explore the availability of combination therapies
2.2 Expand the prevalence of low cost therapies in developing countries

3. Global Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

3.1 Impact Analysis of Macro Economic Factors on Global Percutaneous Transluminal Angioplasty (PTA) Market
3.2 Epidemiology: Global Chronic Disease Prevalence
3.3 Epidemiology: Global Chronic Disease Incidence
3.4 Global Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
3.5 Degree of Impact of Covid-19 on Percutaneous Transluminal Angioplasty (PTA) Market
3.6 Global Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
3.6.1 Global Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
3.6.2 Global Percutaneous Transluminal Angioplasty (PTA) Market Attractiveness Index, By Product Type Overview
3.6.3 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
3.6.4 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
3.6.5 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
3.6.6 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
3.7 Global Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
3.7.1 Global Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
3.7.2 Global Percutaneous Transluminal Angioplasty (PTA) Market Attractiveness Index, By Application Overview
3.7.3 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
3.8.1 Global Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
3.8.2 Global Percutaneous Transluminal Angioplasty (PTA) Market Attractiveness Index, By End User Overview
3.8.3 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)

4. Global Percutaneous Transluminal Angioplasty (PTA) Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot

5. Americas Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

5.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
5.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
5.4 Americas Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
5.5 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
5.5.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
5.5.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
5.5.5 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
5.6.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
5.6.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
5.7.1 Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
5.7.2 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
5.7.3 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
5.7.4 Americas Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Country
5.8.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Country Overview
5.8.2 United States Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.2.1 United States Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
5.8.2.2 United States Percutaneous Transluminal Angioplasty (PTA) Market, By Application
5.8.2.3 United States Percutaneous Transluminal Angioplasty (PTA) Market, By End User
5.8.3 Canada Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.3.1 Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
5.8.3.2 Canada Percutaneous Transluminal Angioplasty (PTA) Market, By Application
5.8.3.3 Canada Percutaneous Transluminal Angioplasty (PTA) Market, By End User
5.8.4 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.4.1 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
5.8.4.2 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By Application
5.8.4.3 Rest of Americas Percutaneous Transluminal Angioplasty (PTA) Market, By End User

6. Europe Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

6.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
6.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
6.4 Europe Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
6.5 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
6.5.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
6.5.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
6.5.5 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
6.6.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
6.6.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
6.7.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
6.7.2 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
6.7.3 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
6.7.4 Europe Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Country
6.8.1 Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Country Overview
6.8.2 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.2.1 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
6.8.2.2 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By Application
6.8.2.3 United Kingdom Percutaneous Transluminal Angioplasty (PTA) Market, By End User
6.8.3 Germany Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.3.1 Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
6.8.3.2 Germany Percutaneous Transluminal Angioplasty (PTA) Market, By Application
6.8.3.3 Germany Percutaneous Transluminal Angioplasty (PTA) Market, By End User
6.8.4 France Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.4.1 France Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
6.8.4.2 France Percutaneous Transluminal Angioplasty (PTA) Market, By Application
6.8.4.3 France Percutaneous Transluminal Angioplasty (PTA) Market, By End User
6.8.5 Spain Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.5.1 Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
6.8.5.2 Spain Percutaneous Transluminal Angioplasty (PTA) Market, By Application
6.8.5.3 Spain Percutaneous Transluminal Angioplasty (PTA) Market, By End User
6.8.6 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.6.1 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
6.8.6.2 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By Application
6.8.6.3 Rest of Europe Percutaneous Transluminal Angioplasty (PTA) Market, By End User

7. Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

7.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
7.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
7.4 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
7.5 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
7.5.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
7.5.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
7.5.5 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Others, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
7.6.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
7.6.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
7.7.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
7.7.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
7.7.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
7.7.4 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Country
7.8.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Country Overview
7.8.2 China Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.2.1 China Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
7.8.2.2 China Percutaneous Transluminal Angioplasty (PTA) Market, By Application
7.8.2.3 China Percutaneous Transluminal Angioplasty (PTA) Market, By End User
7.8.3 Japan Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.3.1 Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
7.8.3.2 Japan Percutaneous Transluminal Angioplasty (PTA) Market, By Application
7.8.3.3 Japan Percutaneous Transluminal Angioplasty (PTA) Market, By End User
7.8.4 India Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.4.1 India Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
7.8.4.2 India Percutaneous Transluminal Angioplasty (PTA) Market, By Application
7.8.4.3 India Percutaneous Transluminal Angioplasty (PTA) Market, By End User
7.8.5 South Korea Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.5.1 South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
7.8.5.2 South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By Application
7.8.5.3 South Korea Percutaneous Transluminal Angioplasty (PTA) Market, By End User
7.8.6 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.6.1 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type
7.8.6.2 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By Application
7.8.6.3 Rest of Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Market, By End User

8. Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Historic and Forecast

8.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Snapshot
8.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Key Factors
8.4 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market: Segment Analysis
8.5 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Product Type
8.5.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Product Type Overview
8.5.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Balloon Catheters, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Stents, By Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Guidewires, By Value, 2020H-2030F (USD Million & CAGR)
8.5.5 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Others, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By Application
8.6.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By Application Overview
8.6.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Coronary Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Segmentation: By End User
8.7.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market, By End User Overview
8.7.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
8.7.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
8.7.4 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)

9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Global Percutaneous Transluminal Angioplasty (PTA) Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Industry Ecosystem Analysis
10.1 Porter Analysis

11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Market Share of Leading Companies
11.3 Company Profiling
11.3.1 Medtronic PLC
11.3.2 Terumo Corporation
11.3.3 Cardinal Health, Inc
11.3.4 Boston Scientific
11.3.5 Teleflex Incorporated
11.3.6 Johnson & Johnson
11.3.7 Abbott Laboratories
11.3.8 Stryker Corporation
11.3.9 Becton Dickinson and Co
11.3.10 Cook Group Inc.

12. About Us and Disclaimer

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

2023-2028 Global And Regional Percutaneous Monitor Device Industry Status And Prospects Profe...
View More
Global Percutaneous Surgical Robot Market Size, Key Players, Research Insights, Emerging Oppo...
View More
2023-2028 Global And Regional Balloon Angioplasty And Heart Stents Industry Status And Prospe...
View More
Global Medical Percutaneous Puncture Robot Market Size, Key Players, Research Insights, Emerg...
View More
Global Cutting Angioplasty Balloons Market Size, Key Players, Research Insights, Emerging Opp...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved